These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 34294165)

  • 1. Exosomal delivery of therapeutic modulators through the blood-brain barrier; promise and pitfalls.
    Heidarzadeh M; Gürsoy-Özdemir Y; Kaya M; Eslami Abriz A; Zarebkohan A; Rahbarghazi R; Sokullu E
    Cell Biosci; 2021 Jul; 11(1):142. PubMed ID: 34294165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological and pathological consequences of exosomes at the blood-brain-barrier interface.
    Salimi L; Seyedaghamiri F; Karimipour M; Mobarak H; Mardi N; Taghavi M; Rahbarghazi R
    Cell Commun Signal; 2023 May; 21(1):118. PubMed ID: 37208741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into Exosome Transport through the Blood-Brain Barrier and the Potential Therapeutical Applications in Brain Diseases.
    Abdelsalam M; Ahmed M; Osaid Z; Hamoudi R; Harati R
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges.
    Choi H; Choi K; Kim DH; Oh BK; Yim H; Jo S; Choi C
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Navigating the brain: the role of exosomal shuttles in precision therapeutics.
    Fatima S; Qaiser A; Andleeb S; Hashmi AH; Manzoor S
    Front Neurol; 2023; 14():1324216. PubMed ID: 38304326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
    Yamashita T; Takahashi Y; Takakura Y
    Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes form tunneling nanotubes (TUNTs) in the blood-brain barrier: a nano-anatomical perspective of barrier genesis.
    Mentor S; Fisher D
    Front Mol Neurosci; 2022; 15():938315. PubMed ID: 36204136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Strategies for Brain Drug Delivery.
    Dong X
    Theranostics; 2018; 8(6):1481-1493. PubMed ID: 29556336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes in Cardiovascular Medicine.
    Dykes IM
    Cardiol Ther; 2017 Dec; 6(2):225-237. PubMed ID: 28526928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic exosomal miR-193b-3p delivery attenuates neuroinflammation in early brain injury after subarachnoid hemorrhage in mice.
    Lai N; Wu D; Liang T; Pan P; Yuan G; Li X; Li H; Shen H; Wang Z; Chen G
    J Neuroinflammation; 2020 Feb; 17(1):74. PubMed ID: 32098619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcellular brain drug delivery: A review on recent advancements.
    Azarmi M; Maleki H; Nikkam N; Malekinejad H
    Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier.
    Matsumoto J; Stewart T; Banks WA; Zhang J
    Curr Pharm Des; 2017; 23(40):6206-6214. PubMed ID: 28914201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.
    Rempe R; Cramer S; Qiao R; Galla HJ
    Cell Tissue Res; 2014 Mar; 355(3):717-26. PubMed ID: 24585360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Trends in Nanotechnology Toward CNS Diseases: Lipid-Based Nanoparticles and Exosomes for Targeted Therapeutic Delivery.
    Cardoso AM; Guedes JR; Cardoso AL; Morais C; Cunha P; Viegas AT; Costa R; Jurado A; Pedroso de Lima MC
    Int Rev Neurobiol; 2016; 130():1-40. PubMed ID: 27678173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.